TERT promoter mutations are useful to distinguish phyllodes tumours with a fibroadenoma‐like morphology from cellular fibroadenomas

Documenti analoghi

• Frequent BRAF V600E and TERT promoter‐mutated renal epithelial‐predominant Wilms tumours with metanephric features: a distinct subset within the Wilms tumour spectrum?
  di: Yuemei Xu, et al.
  Pubblicazione: (2025)
• Artificial intelligence modelling in grading breast phyllodes tumours
  di: Jessica Ee Ting Koong, et al.
  Pubblicazione: (2026)
• TERT promoter–mutated thyroid carcinomas: prognostic and histologic insights according to the WHO 2022 classification
  di: Seung Eun Lee, et al.
  Pubblicazione: (2026)
• Molecular pathology of phyllodes tumours of the breast—much more than MED12
  di: Jia‐Min B Pang, et al.
  Pubblicazione: (2026)
• Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutations
  di: Xuan Tao, et al.
  Pubblicazione: (2025)